António Pinto

Active 1978–2026

Also published as
Antonio Pinto · Antonio PINTO · Antônio Pinto
238
Papers
19,212
Citations
83
h-index
184
i10-index

Citations

Citations per year for António Pinto1983: 1 citations1984: 3 citations1985: 5 citations1986: 2 citations1987: 6 citations1988: 13 citations1989: 9 citations1990: 14 citations1991: 8 citations1992: 11 citations1993: 7 citations1994: 6 citations1995: 9 citations1996: 16 citations1997: 18 citations1998: 18 citations1999: 21 citations2000: 21 citations2001: 28 citations2002: 27 citations2003: 36 citations2004: 20 citations2005: 31 citations2006: 38 citations2007: 54 citations2008: 75 citations2009: 102 citations2010: 95 citations2011: 118 citations2012: 105 citations2013: 127 citations2014: 121 citations2015: 122 citations2016: 138 citations2017: 112 citations2018: 141 citations2019: 496 citations2020: 659 citations2021: 720 citations2022: 617 citations2023: 477 citations2024: 798 citations2025: 406 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,559 citing papers, 18.7% of this breakdownChina: 904 citing papers, 10.8% of this breakdownItaly: 691 citing papers, 8.3% of this breakdownUnited Kingdom: 517 citing papers, 6.2% of this breakdownGermany: 486 citing papers, 5.8% of this breakdownFrance: 286 citing papers, 3.4% of this breakdownCanada: 264 citing papers, 3.2% of this breakdownSpain: 263 citing papers, 3.1% of this breakdownBrazil: 203 citing papers, 2.4% of this breakdownAustralia: 202 citing papers, 2.4% of this breakdownSwitzerland: 189 citing papers, 2.3% of this breakdownIndia: 189 citing papers, 2.3% of this breakdown
0%18.7%Other 31.1%

Fields

  • Medicine57.4%
  • Biochemistry, Genetics and Molecular Biology14.3%
  • Neuroscience5.8%
  • Computer Science4.5%
  • Immunology and Microbiology4.1%
  • Pharmacology, Toxicology and Pharmaceutics2.8%
  • Other11.1%

Topics

  • Lymphoma Diagnosis and Treatment4.6%
  • CAR-T cell therapy research2.7%
  • Neuroinflammation and Neurodegeneration Mechanisms2.1%
  • Chronic Lymphocytic Leukemia Research1.6%
  • Liver Disease Diagnosis and Treatment1.4%
  • Immune Cell Function and Interaction1.4%
  • Other86.2%

Coauthors

All papers

Open in search
  1. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher R. Flowers, Gilles Salles - New England Journal of Medicine 2021 cited by 843

  2. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches

    Authors: , , , , - International Journal of Molecular Sciences 2020 cited by 605

  3. Metabolic and Vascular Effect of the Mediterranean Diet

    Authors: , , , , , - International Journal of Molecular Sciences 2019 cited by 269

  4. AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 421

  5. Diabetes and Ischemic Stroke: An Old and New Relationship an Overview of the Close Interaction between These Diseases

    Authors: , , , , , - International Journal of Molecular Sciences 2022 cited by 216

  6. RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tom Moore, Meike Schneider, Wolfgang Jacob, Maja Weisser, Martin Hutchings, Caroline Hasselbalch Riley - Blood 2022 cited by 90

  7. Effects of noise on vascular function, oxidative stress, and inflammation: mechanistic insight from studies in mice

    Authors: , , , , , , , , , , , , , , , - European Heart Journal 2017 cited by 271

  8. Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 424

  9. Crucial role for Nox2 and sleep deprivation in aircraft noise-induced vascular and cerebral oxidative stress, inflammation, and gene regulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2018 cited by 220

  10. Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes

    Authors: , , , , , , - eLife 2017 cited by 217

  11. Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial

    Authors: , , , , , , , , , , , - Cardiovascular Diabetology 2021 cited by 67

  12. Inflammatory Cytokines in Acute Ischemic Stroke

    Authors: , , , , - Current Pharmaceutical Design 2008 cited by 330

  13. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrizia Tosi, Francesco Lanza, Massimo Massaia, Mauro Turrini, Felicetto Ferrara, Carmela Gurrieri, Daniele Vallisa, Maurizio Martelli, Enrico Derenzini, Attilio Guarini, Annarita Conconi, Annarosa Cuccaro, Laura Cudillo, Domenico Russo, Fabrizio Ciambelli, Anna Maria Scattolin, Mario Luppi, Carmine Selleri, Elettra Ortu La Barbera, Celestino Ferrandina, Nicola Di Renzo, Attilio Olivieri, Monica Bocchia, Massimo Gentile, Francesco Marchesi, Pellegrino Musto, Augusto B. Federici, Anna Candoni, Adriano Venditti, Carmen Fava, Antonio Pinto, Piero Galieni, Luigi Rigacci, Daniele Armiento, Fabrizio Pane, Margherita Oberti, Patrizia Zappasodi, Carlo Visco, Matteo Franchi, Paolo Grossi, Lorenza Bertù, Giovanni Corrao, Livio Pagano, Paolo Corradini - The Lancet Haematology 2020 cited by 554

  14. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study

    Authors: , , , , , , , , , , , , , , , , , , , - Cardiovascular Diabetology 2018 cited by 79

  15. Ketogenic Diet, Physical Activity, and Hypertension—A Narrative Review

    Authors: , , , , , , , - Nutrients 2021 cited by 70

  16. The Role of Artificial Intelligence and Machine Learning Models in Antimicrobial Stewardship in Public Health: A Narrative Review

    Authors: , , , , - Antibiotics 2025 cited by 66

  17. Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine

    Authors: , , , , , - Current Pharmaceutical Design 2016 cited by 118

  18. The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , - Medicine 2016 cited by 79

  19. Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers

    Authors: , , , , , , , , , , - Cancers 2021 cited by 127

  20. End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA

    Authors: , , , , , , , , , , , , , , , , , , - Blood Advances 2021 cited by 57

  21. Boosting additive circular economy ecosystems using blockchain: An exploratory case study

    Authors: , , , , - Computers & Industrial Engineering, Comput. Ind. Eng. 2022 cited by 51

  22. Glofitamab + Pola-R-CHP in patients with previously untreated diffuse large B-cell lymphoma (DLBCL): Results from a phase Ib study.

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 23

  23. Diabetic Foot Syndrome as a Possible Cardiovascular Marker in Diabetic Patients

    Authors: , , - Journal of Diabetes Research 2015 cited by 131

  24. Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandra Dondi, Donato Mannina, Massimo Federico, on behalf of Fondazione Italiana Linfomi - Journal of Clinical Oncology 2021 cited by 92